Dan Leonard
Stock Analyst at UBS
(3.90)
# 629
Out of 4,966 analysts
299
Total ratings
54.82%
Success rate
8.38%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $14.01 | -7.21% | 6 | Aug 8, 2025 | |
| EXAS Exact Sciences | Maintains: Neutral | $61 → $53 | $47.42 | +11.77% | 10 | Aug 7, 2025 | |
| CERT Certara | Maintains: Buy | $18 → $15 | $10.84 | +38.38% | 10 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $300 → $305 | $475.51 | -35.86% | 2 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $460 → $500 | $492.72 | +1.48% | 17 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Buy | $240 → $225 | $205.82 | +9.32% | 18 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $185 → $225 | $190.81 | +17.92% | 16 | Jul 23, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,301.04 | +3.76% | 9 | May 20, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $54.63 | +28.13% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $33.98 | +32.43% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $297.88 | +4.07% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $299.50 | +3.51% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $70 | $67.42 | +3.83% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $90.11 | +27.62% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $98.79 | +0.21% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $13.47 | +85.60% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $163.31 | +13.28% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $8.86 | +1.58% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $22.17 | +57.87% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $125.66 | +19.37% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $99.96 | +100.08% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.42 | +354.55% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $168.25 | -58.40% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $13.18 | -46.89% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $301.80 | +14.31% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $177.94 | +46.12% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $181.64 | -20.17% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $67.12 | +34.09% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $46.50 | +36.88% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $277.99 | +22.31% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $23.01 | +4.30% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $6.37 | +449.45% | 12 | Aug 14, 2019 |
10x Genomics
Aug 8, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $14.01
Upside: -7.21%
Exact Sciences
Aug 7, 2025
Maintains: Neutral
Price Target: $61 → $53
Current: $47.42
Upside: +11.77%
Certara
Aug 7, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $10.84
Upside: +38.38%
Medpace Holdings
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $475.51
Upside: -35.86%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Neutral
Price Target: $460 → $500
Current: $492.72
Upside: +1.48%
Danaher
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $205.82
Upside: +9.32%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $185 → $225
Current: $190.81
Upside: +17.92%
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,301.04
Upside: +3.76%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $54.63
Upside: +28.13%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $33.98
Upside: +32.43%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $297.88
Upside: +4.07%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $299.50
Upside: +3.51%
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $67.42
Upside: +3.83%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $90.11
Upside: +27.62%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $98.79
Upside: +0.21%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $13.47
Upside: +85.60%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $163.31
Upside: +13.28%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $8.86
Upside: +1.58%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $22.17
Upside: +57.87%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $125.66
Upside: +19.37%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $99.96
Upside: +100.08%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.42
Upside: +354.55%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $168.25
Upside: -58.40%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $13.18
Upside: -46.89%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $301.80
Upside: +14.31%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $177.94
Upside: +46.12%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $181.64
Upside: -20.17%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $67.12
Upside: +34.09%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $46.50
Upside: +36.88%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $277.99
Upside: +22.31%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $23.01
Upside: +4.30%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $6.37
Upside: +449.45%